These results suggest that mitochondrial dysfunction and major pathological factors, such as Aβ processes, tau hyperphosphorylation, and neuroinflammation, may potentiate each other by forming a vicious cycle during AD development and progression, suggesting that mitochondrial dysfunction may be a potential target for AD treatment 2, 12, 13. Here, MAPT is linked to Alzheimer disease.